+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Humanized Mouse Model Market 2020-2024 - Product Image

Global Humanized Mouse Model Market 2020-2024

  • ID: 5031202
  • Report
  • May 2020
  • Region: Global
  • 120 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Champions Oncology Inc.
  • genOway
  • HuMurine Technologies
  • JSR Corp.
  • Taconic Biosciences Inc.
  • The Jackson Laboratory
  • MORE
Global Humanized Mouse Model Market 2020-2024

The humanized mouse model market is poised to grow by $ 74.72 million during 2020-2024 progressing at a CAGR of 12% during the forecast period. This report on the humanized mouse model market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the rising focus on preventing the spread of pandemics and innovative applications. In addition, rising focus on preventing the spread of pandemics is anticipated to boost the growth of the market as well.

The humanized mouse model market analysis includes product segment and geographic landscapes

The humanized mouse model market is segmented as below:

By Product
  • Genetically humanized mouse model
  • Cell-based humanized mouse model
By Geographic Landscapes
  • North America
  • Europe
  • Asia
  • ROW
This study identifies growing adoption of personalized medicine as one of the prime reasons driving the humanized mouse model market growth during the next few years.

The humanized mouse model market covers the following areas:
  • Humanized mouse model market sizing
  • Humanized mouse model market forecast
  • Humanized mouse model market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading humanized mouse model market vendors that include Champions Oncology Inc., Charles River Laboratories International Inc., genOway, Horizon Discovery Group Plc, HuMurine Technologies, ingenious targeting laboratory, JSR Corp., Taconic Biosciences Inc., The Jackson Laboratory, and TRANS GENIC Inc.. Also, the humanized mouse model market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The research presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. This market research report provides a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Champions Oncology Inc.
  • genOway
  • HuMurine Technologies
  • JSR Corp.
  • Taconic Biosciences Inc.
  • The Jackson Laboratory
  • MORE
Executive Summary
  • Market Overview
Market Landscape
  • Market ecosystem
  • Value chain analysis
Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024
Five Forces Analysis
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
Market Segmentation by Product
  • Market segments
  • Comparison by Product
  • Genetically humanized mouse model - Market size and forecast 2019-2024
  • Cell-based humanized mouse model - Market size and forecast 2019-2024
  • Market opportunity by Product
Market Segmentation by End-user
  • Market segments
  • Comparison by end-user
  • PB companies - Market size and forecast 2019-2024
  • CROs - Market size and forecast 2019-2024
  • AR institutions - Market size and forecast 2019-2024
  • Market opportunity by end-user
Customer landscape
  • Overview
Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends
Vendor Landscape
  • Competitive scenario
  • Vendor landscape
  • Landscape disruption
  • Industry risks
Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • Champions Oncology Inc.
  • Charles River Laboratories International Inc.
  • genOway
  • Horizon Discovery Group Plc
  • HuMurine Technologies
  • ingenious targeting laboratory
  • JSR Corp.
  • Taconic Biosciences Inc.
  • The Jackson Laboratory
  • TRANS GENIC Inc.
Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations
List of Exhibits
1: Key Finding 1
2: Key Finding 2
3: Key Finding 3
4: Key Finding 5
5: Key Finding 6
6: Key Finding 7
7: Key Finding 8
8: Key Finding 9
9: Parent market
10: Market characteristics
11: Offerings of vendors included in the market definition
12: Market segments
13: Global - Market size and forecast 2019 - 2024 ($ million)
14: Global market: Year-over-year growth 2019 - 2024 (%)
15: Five forces analysis 2019 & 2024
16: Bargaining power of buyers
17: Bargaining power of suppliers
18: Threat of new entrants
19: Threat of substitutes
20: Threat of rivalry
21: Market condition - Five forces 2019
22: Product - Market share 2019-2024 (%)
23: Comparison by Product
24: Genetically humanized mouse model - Market size and forecast 2019-2024 ($ million)
25: Genetically humanized mouse model - Year-over-year growth 2019-2024 (%)
26: Cell-based humanized mouse model - Market size and forecast 2019-2024 ($ million)
27: Cell-based humanized mouse model - Year-over-year growth 2019-2024 (%)
28: Market opportunity by Product
29: End user - Market share 2019-2024 (%)
30: Comparison by End user
31: PB companies - Market size and forecast 2019-2024 ($ million)
32: PB companies - Year-over-year growth 2019-2024 (%)
33: CROs - Market size and forecast 2019-2024 ($ million)
34: CROs - Year-over-year growth 2019-2024 (%)
35: AR institutions - Market size and forecast 2019-2024 ($ million)
36: AR institutions - Year-over-year growth 2019-2024 (%)
37: Market opportunity by End user
38: Customer landscape
39: Market share by geography 2019-2024 (%)
40: Geographic comparison
41: North America - Market size and forecast 2019-2024 ($ million)
42: North America - Year-over-year growth 2019-2024 (%)
43: Europe - Market size and forecast 2019-2024 ($ million)
44: Europe - Year-over-year growth 2019-2024 (%)
45: Asia - Market size and forecast 2019-2024 ($ million)
46: Asia - Year-over-year growth 2019-2024 (%)
47: ROW - Market size and forecast 2019-2024 ($ million)
48: ROW - Year-over-year growth 2019-2024 (%)
49: Key leading countries
50: Market opportunity by geography ($ million)
51: Impact of drivers and challenges
52: Vendor landscape
53: Landscape disruption
54: Industry risks
55: Vendors covered
56: Market positioning of vendors
57: Champions Oncology Inc. - Overview
58: Champions Oncology Inc. - Business segments
59: Champions Oncology Inc. - Key offerings
60: Champions Oncology Inc. - Key customers
61: Champions Oncology Inc. - Segment focus
62: Charles River Laboratories International Inc. - Overview
63: Charles River Laboratories International Inc. - Product and service
64: Charles River Laboratories International Inc. - Key offerings
65: Charles River Laboratories International Inc. - Key customers
66: Charles River Laboratories International Inc. - Segment focus
67: genOway - Overview
68: genOway - Business segments
69: genOway - Key offerings
70: genOway - Key customers
71: genOway - Segment focus
72: Horizon Discovery Group Plc - Overview
73: Horizon Discovery Group Plc - Business segments
74: Horizon Discovery Group Plc - Key offerings
75: Horizon Discovery Group Plc - Key customers
76: Horizon Discovery Group Plc - Segment focus
77: HuMurine Technologies - Overview
78: HuMurine Technologies - Business segments
79: HuMurine Technologies - Key offerings
80: HuMurine Technologies - Key customers
81: HuMurine Technologies - Segment focus
82: ingenious targeting laboratory - Overview
83: ingenious targeting laboratory - Business segments
84: ingenious targeting laboratory - Key offerings
85: ingenious targeting laboratory - Key customers
86: ingenious targeting laboratory - Segment focus
87: JSR Corp. - Overview
88: JSR Corp. - Business segments
89: JSR Corp. - Key offerings
90: JSR Corp. - Key customers
91: JSR Corp. - Segment focus
92: Taconic Biosciences Inc. - Overview
93: Taconic Biosciences Inc. - Business segments
94: Taconic Biosciences Inc. - Key offerings
95: Taconic Biosciences Inc. - Key customers
96: Taconic Biosciences Inc. - Segment focus
97: The Jackson Laboratory - Overview
98: The Jackson Laboratory - Business segments
99: The Jackson Laboratory - Key offerings
100: The Jackson Laboratory - Key customers
101: The Jackson Laboratory - Segment focus
102: TRANS GENIC Inc. - Overview
103: TRANS GENIC Inc. - Business segments
104: TRANS GENIC Inc. - Key offerings
105: TRANS GENIC Inc. - Key customers
106: TRANS GENIC Inc. - Segment focus
107: Currency conversion rates for US$
108: Research Methodology
109: Validation techniques employed for market sizing
110: Information sources
111: List of abbreviations
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • Champions Oncology Inc.
  • genOway
  • HuMurine Technologies
  • JSR Corp.
  • Taconic Biosciences Inc.
  • The Jackson Laboratory
  • MORE
The publisher recognizes the following companies as the key players in the global humanized mouse model market: Champions Oncology Inc., Charles River Laboratories International Inc., genOway, Horizon Discovery Group Plc, HuMurine Technologies, ingenious targeting laboratory, JSR Corp., Taconic Biosciences Inc., The Jackson Laboratory, and TRANS GENIC Inc..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is growing adoption of personalized medicine ."

According to the report, one of the major drivers for this market is the tising focus on preventing the spread of pandemics.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
  • Champions Oncology Inc.
  • Charles River Laboratories International Inc.
  • genOway
  • Horizon Discovery Group Plc
  • HuMurine Technologies
  • ingenious targeting laboratory
  • JSR Corp.
  • Taconic Biosciences Inc.
  • The Jackson Laboratory
  • TRANS GENIC Inc.
Note: Product cover images may vary from those shown
Adroll
adroll